Flavonoid-mediated modulation of Tau protein: Implications for targeted therapeutics and clinical relevance in Tau-related disorders

Rayane Hedna, Emmanuelle T. Relave, Maxime Robin, Hervé Kovacic, Gilles Breuzard

Open source

DOI
10.1016/j.ejmcr.2025.100309
Published
2025-12
Container
European Journal of Medicinal Chemistry Reports
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ejmcr.2025.100309,
  title = {Flavonoid-mediated modulation of Tau protein: Implications for targeted therapeutics and clinical relevance in Tau-related disorders},
  author = {Rayane Hedna and Emmanuelle T. Relave and Maxime Robin and Hervé Kovacic and Gilles Breuzard},
  year = {2025},
  journal = {European Journal of Medicinal Chemistry Reports},
  doi = {10.1016/j.ejmcr.2025.100309},
  url = {https://doi.org/10.1016/j.ejmcr.2025.100309}
}

RIS

TY  - JOUR
TI  - Flavonoid-mediated modulation of Tau protein: Implications for targeted therapeutics and clinical relevance in Tau-related disorders
AU  - Rayane Hedna
AU  - Emmanuelle T. Relave
AU  - Maxime Robin
AU  - Hervé Kovacic
AU  - Gilles Breuzard
PY  - 2025
JO  - European Journal of Medicinal Chemistry Reports
DO  - 10.1016/j.ejmcr.2025.100309
UR  - https://doi.org/10.1016/j.ejmcr.2025.100309
ER  - 

APA

Hedna, R., Relave, E. T., Robin, M., Kovacic, H., & Breuzard, G. (2025). Flavonoid-mediated modulation of Tau protein: Implications for targeted therapeutics and clinical relevance in Tau-related disorders. European Journal of Medicinal Chemistry Reports. https://doi.org/10.1016/j.ejmcr.2025.100309

Source records